An international team of researchers at the University of Manchester, Baylor College of Medicine and collaborating ...

highly potent and selective PPAR-α agonist known as LY518674 in patients with lipid disorders. In the first study, 309 patients with atherogenic dyslipidemia (mean age 54.2 years, 68.9% men ...

The following is a summary of “Metabolic complications and clinical outcomes of non-functioning adrenal incidentalomas: a ...

PSORIASIS is a chronic inflammatory skin disease influenced by both genetic and environmental factors, affecting ...

Future research should continue to explore PTGA-related mechanisms and therapies, advancing our knowledge and treatment ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer. A new process ...

Time-restricted feeding (TRF) benefits metabolic health, yet sex differences in its effects are often overlooked. A study by Sichuan Agricultural University published in Life Metabolism reveals TRF ...

With this vision, Sukh Dev and his team delivered powerful solutions to treat lipid disorders and minimise the risk of early pregnancy loss, and also found cures for parasites plaguing livestock ...

Marama Labs' CloudSpec speeds up lipid nanoparticle analysis, cutting lab times from hours to seconds for gene therapy and ...

This radical new way of the regulation of chloride co-transporter activity linked with membrane lipid expression suggests new therapeutical strategies to treat epilepsy. By increasing the general ...

A unique form of treatment has the ability to filter the LDL out of a patient's bloodstream. However, it is only available at one hospital in the entire state.

Her team is a member of the Research Program Unit, Research Program of Clinical and Molecular Metabolism at the University of Helsinki. Her research team has a focus on lipid lipoprotein metabolism in ...